Results 111 to 120 of about 13,623 (265)
Advanced Science, Volume 13, Issue 5, 27 January 2026.A proposed mechanism to explain the role of CYP4X1/sEH‐14,15‐EET‐EA system in colon cancer immune escape. 14,15‐EET‐EA, 14,15‐epoxyeicosatrienoic acid‐ethanolamide; sEH, soluble epoxide hydrolase; CYP4X1, cytochrome P450 4X1; GPR119, G‐protein coupled receptor 119; EGFR, epidermal growth factor receptor; Gs, Gαs subunit; cAMP, cyclic adenosine ...
Min Mo +10 more
wiley +1 more source
The Genetic Wiring of Plant Trichomes: From Initiation to Fate Specification
Advanced Science, Volume 13, Issue 4, 19 January 2026.Plant trichomes are not just simple hairs but metabolic powerhouses shaped by complex genetic programs. While the MYB‐bHLH‐WD40 module is well studied in Arabidopsis, recent findings reveal that HD‐Zip IV transcription factors drive multicellular and glandular trichome development through dose‐dependent mechanisms.
Meng Li +3 more
wiley +1 more source
Advanced Science, Volume 13, Issue 2, 9 January 2026.The advent of aptamers has highlighted their potential as alternatives to antibodies, overcoming limitations of structural instability and production cost. However, conventional approaches such as SELEX remain slow and labor‐intensive. This review examines recent advances in aptamer engineering, emphasizing in vitro and AI‐driven in silico strategies ...
John V. L. Nguyen +5 more
wiley +1 more source
Characterization of the synthetic cannabinoid MDMB-CHMCZCA [PDF]
, 2016 Carina Weber +5 more
openalex +1 more source
Scent Goes Digital: The Role of Insect Odorant Binding Proteins in Modern Technology
BioFactors, Volume 52, Issue 1, January/February 2026.This review delves into bioinspired olfactory biosensors, focusing on insect odorant binding proteins (OBPs) as core elements of hybrid bionic platforms for volatile compound detection. Highlighting the development of the biological electronic nose (BE‐NOSE), it examines current prototypes, outlines advantages over conventional methods, and explores ...
Maddalena Ventura +5 more
wiley +1 more source
Critical appraisal of the potential use of cannabinoids in cancer management
Cancer Management and Research, 2013 Belinda J Cridge, Rhonda J Rosengren Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand Abstract: Cannabinoids have been attracting a great deal of interest as potential anticancer agents.
Cridge BJ, Rosengren RJ
doaj
Comparative Analysis of Theoretical and Empirical Data of Synthetic Cannabinoids
, 2018 Ibrahim Olasegun Abdulsalami
openalex +1 more source
Clinical Pharmacology &Therapeutics, Volume 119, Issue 1, Page 147-157, January 2026.Cannabidiol (CBD) is approved as an adjunctive treatment of seizures associated with Dravet syndrome, Lennox–Gastaut Syndrome, and tuberous sclerosis. Its therapeutic and adverse effects are thought to arise, at least partly, from a pharmacokinetic interaction with clobazam, another anti‐seizure medication (ASM).
Andriy A. Gorbenko +7 more
wiley +1 more source
The Journal of Clinical Pharmacology, Volume 66, Issue 1, January 2026.Abstract There is a paucity of high‐quality evidence on the clinical efficacy of cannabis‐based medicinal products (CBMPs). The objective of this study was to perform trajectory k‐means clustering of health‐related quality of life (HRQoL) outcomes in patients prescribed CBMPs to identify distinct response patterns and baseline predictors of treatment ...
Simon Erridge +10 more
wiley +1 more source